Financial News · Live Terminal

Page 262 of 299

Raymond James Upgrades Ball to Outperform From Market Perform, Price Target is $73

Ball (BALL) has an average rating of overweight and mean price target of $71.46, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$BALL

Research65d ago

Research Alert: CFRA Initiates Coverage On Shares Of Klarna Group Plc With A Hold Rating

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We initiate coverage on KLAR with a Hold rating and target of $16, 13.9x our 2028 EPS estimate, a discount to its historical trading average (38.7x) but more aligned with peers (13.6x). We project an LPS of $0.14 in 2026 and EPS of $0.68 in 2027 and $1.15 in 2028. While KLAR benefits from secular BNPL tailwinds and market-leading scale across 118M consumers and 966K merchants, near-term profitability remains pressured by Fair Financing's rapid expansion that front-loads provisions while deferring revenue recognition. The Klarna Card's explosive adoption and AI-led operational leverage provide compelling long-term upside, but execution risks cloud the outlook. Management has missed transaction margin dollar guidance despite beating revenue expectations, raising questions about its ability to forecast the P&L impact of its own strategic initiatives. A federal securities lawsuit alleging the IPO prospectus understated credit risk exposure adds near-term overhang as shares have fallen over 60% from the IPO price.

$KLAR

Research65d ago

Research Alert: CFRA Initiates Coverage On Riocan Real Estate Investment Trust With A Hold View

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We initiate coverage on shares of REI.UN with a 12-month target price of $22, applying a forward P/FFO multiple of 13.1x to our 2026 FFO estimate, a premium to the three-year forward average of 10.4x. We start our 2026 FFO per share estimate at $1.68 and 2027 at $1.72. We have an overall positive view on REI as it has pivoted to a pure-play necessity retail REIT after exiting all residential assets, but believe it already trades at a premium that reflects this transition. REI has near-record occupancy and strong re-leasing spreads over 15%, but is unable to grow NOI faster than 3.5% in the near term due to accelerating interest expense growth related to refinancing near-term obligations from low rates through 2027. REI's grocery-anchor focus (85% of centers, targeting 90%) and concentration in Canada's high-demographic major markets (277K population, $155K income within 5km) should provide strong cash flow that enables management to further pay down debt (currently at 8.6x net debt to adjusted EBITDA).

$REI.UN

Research65d ago

Research Alert: Rio Tinto Delivers 9% Copper Equivalent Growth; All 2026 Guidance Unchanged

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Rio Tinto delivered solid Q1 2026 performance with 9% copper equivalent production growth despite weather challenges. Iron ore production reached 78.8Mt (up 13%) with strong performance, though sales growth was constrained to 2% at 72.4Mt due to tropical cyclones disrupting shipments by ~8Mt. We believe the diversified portfolio demonstrated resilience and scale advantages, with Oyu Tolgoi copper surging 56% to 102kt and Simandou achieving its first full shipment milestone. Management maintained 2026 guidance despite weather impacts, reflecting confidence in operational execution. The company successfully implemented the full USD650M of productivity benefits and completed the Resolution Copper land exchange, with drilling now underway at one of the world's largest untapped copper deposits. We expect continued strength from aluminum operations and Oyu Tolgoi's ramp-up toward 500kt annual production from 2028-2036, though two workplace fatalities underscore management's renewed safety focus.

$RIO

Research65d ago

Research Alert: Aapl: Tim Cook Steps Down Earlier Than Thought; Well Planned And Minimizes Risk

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:AAPL announces CEO Tim Cook will step down September 1 after 15 years, with John Ternus (SVP Hardware Engineering) succeeding him, while Cook becomes Executive Chairman. Johny Srouji was promoted to Chief Hardware Officer, expanding his role beyond silicon to oversee all hardware engineering and technologies. We view this well-orchestrated succession as neutral to modestly positive despite being sooner than expected, addressing prior leadership continuity concerns while strategically pivoting from operational excellence to product-centric engineering leadership appropriate for AAPL's push into AI and foldables, among other categories. The four-month transition period with Cook's continued involvement as Executive Chairman mitigates execution risks (with Cook focusing on policy). Ternus brings 25 years of Apple experience, leading the Mac's Apple silicon transition and iPhone evolution. Srouji's elevation ensures continuity in Apple's silicon strategy, which has driven gross margins to the high-40% levels.

$AAPL

Research65d ago

Research Alert: Alk: Q1 Loss Widens On Fuel Headwinds; Company Suspends Full-year Guidance

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:ALK reported Q1 adjusted EPS of -$1.68, widening from -$0.77 in the prior year and missing the -$1.55 consensus, while revenue of $3.3B (+5.2%) met expectations. Unit revenue rose 3.5%, led by strong corporate travel (+19%) and premium segments, but unit costs increased 6.3% from airport, maintenance, and pilot training pressures. The Hawaiian integration and Alaska Accelerate strategy are delivering results ahead of schedule, with Seattle-Tokyo achieving profitability and 90%+ load factors within a year of launch. Management suspended full-year guidance due to fuel cost volatility, though ALK maintains confidence in its long-term trajectory. Looking ahead, Q2 fuel costs are expected to average $4.50 per gallon, representing a 51% sequential increase and $600M headwind equivalent to $3.60/share. We believe the $10 2027 EPS target will be increasingly challenging given current fuel dynamics and guidance suspension, but operational excellence during integration demonstrates management's execution capabilities.

$ALK

Research65d ago

Research Alert: Steel Dynamics Posts Q1 Sales Beat, Eps Miss; Aluminum Operations Drag

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:STLD delivered Q1 2026 EPS of $2.78 vs. $1.44 prior year (86% growth) but missed consensus by $0.01, driven by record steel shipments of 3.6M tons and expanding metal spreads of $64 per ton. Net sales advanced 19% Y/Y to $5.21B as steel operating income improved substantially to $557M from $275M, validating our thesis that 2H 2025 represented a cyclical trough with strengthening demand across energy, construction, automotive, and industrial sectors driving pricing power. Management expects sharp aluminum facility improvement beginning in Q2, targeting 90% utilization by year-end 2026 to achieve the $650M-$700M through-cycle EBITDA target as customer qualifications advance. The company maintained robust liquidity of $2.0B while increasing the dividend 6% to $0.53 per share and repurchasing $115M in shares. We expect free cash flow generation to inflect meaningfully as major growth capex declines to $600M and structural EBITDA improvements approach realization.

$STLD

Research65d ago

Research Alert: Psk Q1: Strong Leasing Offsets Pricing, Rate Headwinds

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:PSK delivered 11% growth in funds from operations to CAD94.9M (CAD0.41/share) as 4% production growth to 26,293 BOE/d offset 5% pricing decline to CAD50.08/BOE, driving 4% revenue growth to CAD133.8M. Net earnings declined 4% to CAD55.8M (CAD0.24/share), while other revenue surged 87% to CAD15.3M from exceptional leasing activity. Record Duvernay activity with 26 wells spud, including 20 in the prolific West Shale Basin, supports our positive outlook as management expects this will drive meaningful oil production growth in 2H 2026. Multilateral drilling expanded to 33% of new wells from 20% previously, demonstrating operational efficiency improvements. We view the 65% funds from operations payout ratio through the CAD0.265/share quarterly dividend as sustainable, while CAD8.3M in share buybacks and CAD18.8M net debt reduction to CAD257.7M demonstrate disciplined capital allocation that should support future returns.

$PSK

Research65d ago

Research Alert: Zion Q1 Earnings Beat Driven By Pristine Credit Quality

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:ZION posted strong Q1 2026 results, with GAAP EPS of $1.56 vs $1.13 prior year, beating consensus by $0.13. Credit quality was exceptional, with provisions flipping to a $7M benefit, net charge-offs at just 3 bps, and nonperforming assets at 0.48%, the lowest in seven quarters. Our belief that 2025 credit challenges would not persist into 2026 received validation as ZION delivered some of the industry's best credit metrics. Net interest income grew 6% Y/Y, with margin expansion to 3.27% from 3.10% prior year, though declining 4 bps sequentially due to lower earning asset yields. Balance sheet growth was solid with loans increasing 2% to $61.3B and customer deposits growing 3% to $73.1B. Fee income performance was strong, with customer-related noninterest income up 9% due to loan-related fees (+35%) and retail banking fees (+18%). We are not overly concerned with the sequential margin decline as similar trends were observed across the industry.

$ZION

Research65d ago

Research Alert: CFRA Maintains Sell Opinion On Shares Of Bank Of Hawaii Corporation

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:After digesting Q1 2026 earnings, we increase our 12-month target price by $6 to $57, 8.3x our 2027 EPS estimate, a discount to the peer average of 10.9x, as weak growth prospects outweigh the benefits of limited competition in Hawaii. We raise our 2026 EPS estimate to $5.95 from $5.33 and 2027's to $6.84 from $5.94. Our revenue projections are $801M in 2026 and $858M in 2027. BOH's Q1 results showed positive momentum, with net interest income growing for the eighth straight quarter and credit quality remaining solid. Despite these strengths, we believe the stock is overvalued given weak fundamental growth trends. Loan balances have been flat Y/Y, while deposits have grown only 1% over four years. Furthermore, although BOH maintains strong capital levels (12.1% CET1 ratio), the bank faces unusual vulnerability to rising long-term interest rates due to significant unrealized losses in its securities portfolio. We note BOH's quarterly dividend has been stagnant at $0.70 since mid-2021.

$BOH

Research65d ago

Research Alert: CFRA Keeps Buy Rating On Shares Of Eli Lilly After Kelonia Deal Announcement

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We keep our target price at $1,225, 29.0x our 2027 EPS view, below LLY's five-year historical forward P/E average. We retain our 2026 EPS at $34.71 and lift our 2027 EPS to $42.22 from $42.12. LLY announced today it is acquiring Kelonia Therapeutics for up to $7B to access its iGPS platform, enabling in vivo CAR-T therapy that reprograms T-cells to fight cancer inside the body via a single IV infusion. Kelonia's lead candidate KLN-1010 targets BCMA in multiple myeloma, the second most frequent U.S. blood cancer. Similarly, LLY announced the acquisition of Orna Therapeutics for up to $1B in February to access its circular RNA platform, which offers longer-lasting protein expression, reduced immunogenicity, and larger genetic payloads versus traditional mRNA. These acquisitions reflect LLY's strategy of deploying GLP-1 cash flow to build a diversified pipeline in oncology, autoimmune diseases and next-generation therapeutic modalities, in our view.

$LLY

Research65d ago

ATS Maintained at Buy at Stifel Canada; Price Target Kept at C$52.00

Stifel Canada on Monday maintained its buy rating on the shares of ATS (ATS.TO) and its C$52.00 price target as it sees little impact from a fresh round of U.S. tariffs."We view the expanded Section 232 tariffs on steel and aluminum as not having a material impact to ATS. ATS is a global end-to-end automation provider (Design + Build + Service) of high-performance robotic systems with valuable end-market exposure, including Life Sciences (~60% of sales). Approximately 20% of ATS' revenue is associated with flows into the U.S. from Canada and Europe with a large proportion currently exempt under USMCA with risk mitigation underway, including substantial expansion at Chicago facilities. Although the tariff situation remains fluid and Section 232 raises questions with certain other companies impacted, we believe ATS' global operations, contract protections in-place and the long-term nature of mission-critical projects (12-18 months) provide ample flexibility to navigate at this stage. We are also encouraged by recent insider buying, including new (Jan. start) CEO, Doug Wright and ATS' largest shareholder, Mason Capital at ~C$41/share, near current levels," analyst Justin Keywood wrote.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $45.03, Change: $+0.22, Percent Change: +0.49%

$ATS.TO

Research65d ago

Celestica Price Target Raised to US$350 at TD

TD Securities raised its price target on Celestica (CLS.TO, CLS) to US$350 from US$330 on Monday.Analyst John Shoo maintained a Hold rating on shares of the Canadian multinational electronics manufacturing services company ahead of its Q1 results on April 27."We see a low performance shortfall risk and expect the typical 'beat and raise' pattern to continue," Shoo said in a note to clients."The stock's recent rally nonetheless sets the bar higher and prices in perfect execution," the analyst said."Following improved visibility into 2027, we are adjusting our estimates and increasing CCS growth rates to 44% y/y."(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $541.86, Change: $-1.03, Percent Change: -0.19%

$CLS$CLS.TO

Research65d ago

Algoma Steel Group Maintained at Buy at Stifel Canada Following Investor Meetings; Price Target Kept at C$11.50

Stifel Canada on Monday maintained its buy rating on the shares of Algoma Steel Group (ASTL.TO) and its C$11.50 price target after hosting the company's management for investor meetings."We hosted Rajat Marwah (CEO) and Michael Moraca (CFO) for investor meetings, which we would define as generally positive in the context of the company's current financial outlook. The company is working towards transitioning itself to being a Canadian champion for steel products, including the addition of (1) a beam mill; and (2) broadening its plate opportunity. We believe the company will be a direct and indirect beneficiary of the Canadian Federal Government's spending focus on defense and infrastructure. Valuation remains largely irrelevant given the company is forecast to generate only $35 mm of EBITDA in 2027E, but there are a number of catalysts in 2026E that could positively impact that outcome (particularly CUSMA negotiations). We remain optimistic on the turnaround story, thus retain our BUY rating and $11.50/sh target price," analyst Ian Gillies wrote.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $6.34, Change: $-0.16, Percent Change: -2.46%

$ASTL.TO

Research65d ago

Update: Wedbush Initiates USA Rare Earth at Outperform With $29 Price Target

(Updated to include Wedbush commentary)Wedbush initiated coverage on USA Rare Earth (USAR) with an outperform rating and a $29 price target.The brokerage highlighted the company's Round Top deposit in West Texas, noting that around 72% of its total rare earth oxide content consists of heavy rare earth elements, effectively unique among deposits of this scale outside China, analysts Dan Ives and Sam Brandeis wrote in a Monday note.Rare earth magnets are critical inputs across defense, EVs, semiconductors, and physical artificial intelligence infrastructure, such as compute, robotics, and autonomous, the analysts added.These end markets represent a rapidly growing addressable market and an area where domestic customers are actively seeking to reduce reliance on China, Ives and Brandeis said.USA Rare Earth has an average rating of buy and mean price target of $32.25, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $21.94, Change: $+1.99, Percent Change: +9.95%

$USAR

Research65d ago

Research Alert: CFRA Raises Opinion On Adss Of Hdfc Bank To Buy From Hold

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We keep our forecasted FY 27 (Mar.) EPADS at INR167.50 (USD1.80) and introduce FY 28 EPADS of INR181.80 (USD1.95). We expect HDFC's loan growth to sustain at a low-teen level in FY 27, in line with our projected loan growth for Indian banking sector but softer than HDFC's target of above-industry growth. We see some pressure on NIM from increased mix of term deposits and the 25-bp cut in the repo rate in December 2025, but a shift in HDFC's funding base (toward more stable customer deposits from wholesale funding) will keep its NIM in a stable range in FY 27. We expect cost efficiency to improve as the benefits of technology/digital transformation come through, and credit costs to stay benign given its resilient asset quality. Our target price of USD33 (from USD35) is FY 27 P/EPADS of about 18.3x and a P/B of 2.5x (five-year mean: 22x and 3.3x), factoring in our projected FY 27/FY 28 ROE of 14%-15%, which are comparable to FY 25/FY 26 levels but lower than 16%-17% before the merger.

$HDB

Research65d ago

Research Alert: Cleveland-cliffs Q1 Beat On Sales And Eps Despite Negative Weather Impact

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:CLF posted Q1 adj. loss per share of $0.40 vs. $0.93 loss prior year, beating consensus by $0.02, with revenue of $4.92B up 6.3% Y/Y, beating consensus by 2.7%, led by higher steel shipments of 4.1M net tons and average selling prices of $1,048/ton. Steel operations returned to positive cash margins of $136M vs. $149M loss prior year, though $80M weather-related EBITDA impact masked underlying strength. Trade enforcement supports domestic pricing while POSCO negotiations remain ongoing as a strategic priority. Management reaffirmed full-year 2026 guidance for steel shipments of 16.5-17.0M net tons. We expect sequential quarterly improvement through 2026 with the $500M EBITDA benefit from slab contract termination and positive free cash flow anticipated in Q2. Key monitoring areas include Q2 cash generation, PKX partnership developments, and automotive volume progression under multiyear contracts, with $7.3B net debt requiring continued debt reduction focus as EBITDA improves.

$CLF

Research65d ago

B. Riley Upgrades Axcelis Technologies to Buy From Neutral, Raises Price Target to $150 From $91

Axcelis Technologies (ACLS) has an average rating of overweight and mean price target of $111.67, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$ACLS

Research65d ago

UBS Downgrades BBVA to Neutral Rating, Lowers PT

UBS on Monday downgraded Spanish banking group Banco Bilbao Vizcaya Argentaria (BBVA.MC) to a neutral rating from buy and reduced its price target to 20.50 euros from 22.30 euros.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$BBVA.MC

Research65d ago

Barclays Upgrades UBS Group to Equalweight, Lifts PT

Barclays on Monday upgraded Swiss bank UBS Group (UBSG.SW) to equal weight from underweight and increased its price target to 34 francs from 33 francs.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$UBSG.SW

Showing 5221-5240 of 5966